344 related articles for article (PubMed ID: 5389794)
1. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
Vesell ES; Page JG
J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
[TBL] [Abstract][Full Text] [Related]
2. Genetic control of dicumarol levels in man.
Vesell ES; Page JG
J Clin Invest; 1968 Dec; 47(12):2657-63. PubMed ID: 4177776
[TBL] [Abstract][Full Text] [Related]
3. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
Branch RA; Shand DG; Wilkinson GR; Nies AS
J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
[TBL] [Abstract][Full Text] [Related]
4. Genetic control of drug levels in man: antipyrine.
Vesell ES; Page JG
Science; 1968 Jul; 161(3836):72-3. PubMed ID: 5690279
[TBL] [Abstract][Full Text] [Related]
5. Effect of concomitant administration of cimetidine and phenobarbital on antipyrine elimination and metabolite formation.
Sonne J; Døssing M; Poulsen HE; Pilsgaard H; Rasmussen B; Loft S
Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):194-6. PubMed ID: 3583468
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antipyrine metabolism in cigarette smokers in Indian population.
Uppal R; Garg SK; Sharma PR; Nair CR; Chaudhury RR
Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):269-71. PubMed ID: 7450928
[TBL] [Abstract][Full Text] [Related]
7. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
[TBL] [Abstract][Full Text] [Related]
8. Antipyrine disposition in relation to lowered anticonvulsant plasma level during pregnancy.
Chiba K; Ishizaki T; Tabuchi T; Wagatsuma T; Nakazawa Y
Obstet Gynecol; 1982 Nov; 60(5):620-6. PubMed ID: 6815599
[TBL] [Abstract][Full Text] [Related]
9. Genetic and environmental factors affecting drug response in man.
Vesell ES
Fed Proc; 1972; 31(4):1253-69. PubMed ID: 4114107
[No Abstract] [Full Text] [Related]
10. Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in rats.
Teunissen MW; Van Graft M; Vermeulen NP; Breimer DD
Xenobiotica; 1983 Aug; 13(8):497-502. PubMed ID: 6649682
[TBL] [Abstract][Full Text] [Related]
11. Effect of age on antipyrine metabolism in patients with gastric cancer.
Higuchi T; Nakamura T; Uchino H
J Natl Cancer Inst; 1980 Nov; 65(5):897-900. PubMed ID: 6933259
[TBL] [Abstract][Full Text] [Related]
12. Multiple oral doses of diazepam, oxazepam and phenobarbital to dogs--behavioural effects and correlation with antipyrine half-life.
Albanus L; Jönsson M; Sparf B
Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):63-9. PubMed ID: 300543
[TBL] [Abstract][Full Text] [Related]
13. Ranitidine alters antipyrine metabolism in control and phenobarbital-treated mice.
Espiritu-Quiza MF; Skinner MH; Blaschke TF
Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):631-6. PubMed ID: 2084458
[TBL] [Abstract][Full Text] [Related]
14. Plasma pharmacokinetics of adriamycin and antipyrine and its relation to the therapeutic and toxic effects.
Preiss R; Matthias M; Sohr R; Brockmann B; Hüller H
Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S79-88. PubMed ID: 3842695
[TBL] [Abstract][Full Text] [Related]
15. On the regulation of antipyrine and oxazepam metabolism in man.
Kellermann GH; Luyten-Kellermann M
Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):287-96. PubMed ID: 461954
[TBL] [Abstract][Full Text] [Related]
16. Effect of butalbital and phenobarbital pretreatment on antipyrine clearance in the rat.
Tse FL; Chang T; Jaffe JM
Arch Int Pharmacodyn Ther; 1986 Feb; 279(2):181-94. PubMed ID: 3963935
[TBL] [Abstract][Full Text] [Related]
17. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
van den Broek JM; Teunissen MW; Breimer DD
Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
[TBL] [Abstract][Full Text] [Related]
18. Metabolic disposition of antipyrine in patients with lung cancer.
Tschanz C; Hignite CE; Huffman DH; Azarnoff DL
Cancer Res; 1977 Nov; 37(11):3881-6. PubMed ID: 908027
[TBL] [Abstract][Full Text] [Related]
19. Correlation of aryl hydrocarbon hydroxylase activity of human lymphocyte cultures and plasma elimination rates for antipyrine and phenylbutazone.
Kellermann G; Luyten-Kellermann M; Horning M; Stafford M
Drug Metab Dispos; 1975; 3(1):47-50. PubMed ID: 234834
[TBL] [Abstract][Full Text] [Related]
20. The effect of midazolam administration on the pharmacokinetics of antipyrine in the rat.
White SM; Allen JG; Altman JF
Xenobiotica; 1987 Jul; 17(7):869-73. PubMed ID: 3660856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
